Skip to search formSkip to main contentSkip to account menu

CAT-152

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Maintenance of long-term bleb function by prolonged treatment with CAT-152, an anti-transforming growth factor-b2 (TGF-b2) antibody: Enhanced effects over 5-fluorouracil (5-FU)
2003
2003
Anti-Transforming Growth Factor-β2 Antibody (CAT-152) as a New Post-Operative Modulator of Scarring after Experimental Glaucoma Filtration Surgery
2002
2002
Reducing the risk of bleb failure aided by CAT-152
Norwich, England-A human monoclonal antibody, CAT-152, may help aid bleb survival in patients with primary open-angle glaucoma… 
2002
2002
Anti-TGFß2 Antibody (CAT-152) as a New Post-Operative Modulator of Scarring after Experimental Glaucoma Filtration Surgery
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)